AN vs TSLA

AutoNation's deterministic health scores raise significant concerns, with a weak Piotroski F-Score of 3/9 indicating poor financial health, and no available Altman Z-Score limits distress risk assessment. Despite this, the company shows strong recent earnings growth (22.6% YoY) and beats on earnings surprises, supported by a bullish analyst recommendation and a forward P/E of 10.12 that appears cheap relative to sector peers. However, high leverage (Debt/Equity of 3.90), weak liquidity (Current Ratio 0.79), and declining Q/Q EPS (-8.2%) offset these positives. The stock trades below the growth-based intrinsic value of $490 but above the conservative Graham Number of $159.54, suggesting mixed valuation signals.

Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.